Fluorine-Containing Contrast Medium for MRI Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional contrast media for MRI diagnosis using fluorine as a detection nucleus lack stability and sensitivity in vivo.
Innovation Solution
A fluorine-containing compound represented by General Formula (1) is developed, which includes specific alkyl groups and a nitroxide radical structure, enhancing stability and sensitivity by optimizing the spin-lattice and spin-spin relaxation times, and is used in a contrast medium for MRI diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional contrast media containing metal ions are used, then MRI diagnosis can be performed, but safety concerns arise due to metal ion presence in vivo
Solution Approach 1:
The invention extracts and removes metal ions from the contrast medium system by using a metal-free organic radical compound as the fluorine-containing compound, thereby eliminating metal ion toxicity while maintaining MRI contrast functionality
Solution Approach 2:
The patent employs an organic radical compound that functions as a temporary contrast agent during MRI scanning, after which it is naturally metabolized and excreted without persistent metal ion accumulation in the body
2Reliability
If fluorine-containing compounds easily reduced by ascorbic acid are used, then contrast effect is achieved, but stability in vivo deteriorates due to reduction by reducing agents
Solution Approach 1:
The invention applies local quality by designing specific molecular structures with electron-withdrawing groups positioned at strategic locations, creating localized electron-deficient regions that prevent reduction at the nitroxide radical site while maintaining overall molecular stability
Solution Approach 2:
The patent creates a composite molecular structure combining fluorine-containing groups, electron-withdrawing substituents, and nitroxide radical moieties into a single stable compound that resists reduction by ascorbic acid and other biological reducing agents
3Reliability
If distance between fluorine atom and nitroxide radical is increased, then safety is improved by preventing reduction, but MRI sensitivity decreases
Solution Approach 1:
The invention optimizes the distance parameter between the fluorine atom and nitroxide radical to a specific range that simultaneously provides sufficient stability against reduction while maintaining adequate MRI detection sensitivity through appropriate spin-lattice and spin-spin relaxation times
4Stability of the object's composition
If contrast media with long relaxation times are used, then stability is improved, but MRI sensitivity and image quality deteriorate
Solution Approach 1:
The patent optimizes relaxation time parameters by adjusting molecular structure and composition to achieve intermediate relaxation times that provide both adequate chemical stability and sufficient MRI signal intensity for high-quality imaging
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The fluorine-containing compound provides a highly stable and sensitive MRI image by reducing the distance between the fluorine atom and the nitroxide radical, preventing reduction by reducing agents and ensuring safety without metal ions, thus offering a safer and more effective diagnostic tool.
Implementation Method 1
enhancing stability and sensitivity by optimizing the spin-lattice and spin-spin relaxation times
Implementation Method 2
enhancing stability and sensitivity by optimizing the spin-lattice and spin-spin relaxation times
Implementation Method 3
MRI diagnosis using fluorine as a detection nucleus
Data Source
AI summary
A fluorine-containing compound represented by Formula (1) (R1, R2, R3, and R4 in Formula (1) each represent a C1-10 alkyl group unsubstituted or substituted with a substituent containing no fluorine atoms, and X is any of Formulae (2-1), (2-2), and (2-3).)


